|
1
|
Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family.
|
Mol Microbiol
|
1990
|
4.03
|
|
2
|
Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis.
|
J Antimicrob Chemother
|
1989
|
2.62
|
|
3
|
Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.
|
Br J Dermatol
|
2002
|
2.34
|
|
4
|
Antibiotic-resistant acne: lessons from Europe.
|
Br J Dermatol
|
2003
|
2.22
|
|
5
|
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
|
Br J Dermatol
|
2001
|
2.14
|
|
6
|
A variety of gram-positive bacteria carry mobile mef genes.
|
J Antimicrob Chemother
|
1999
|
2.04
|
|
7
|
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium.
|
Antimicrob Agents Chemother
|
1998
|
1.94
|
|
8
|
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.
|
Antimicrob Agents Chemother
|
1997
|
1.63
|
|
9
|
Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact.
|
Gene
|
1995
|
1.57
|
|
10
|
Minocycline for acne vulgaris: efficacy and safety.
|
Cochrane Database Syst Rev
|
2003
|
1.16
|
|
11
|
Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220.
|
Gene
|
1996
|
1.12
|
|
12
|
Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris.
|
J Invest Dermatol
|
1992
|
1.06
|
|
13
|
Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts.
|
J Antimicrob Chemother
|
1996
|
1.00
|
|
14
|
Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA.
|
Dermatology
|
1998
|
0.97
|
|
15
|
Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne.
|
Br J Dermatol
|
2007
|
0.95
|
|
16
|
Skin carriage of antibiotic-resistant coagulase-negative staphylococci in untreated subjects.
|
J Antimicrob Chemother
|
1990
|
0.91
|
|
17
|
A note on a selective medium for the isolation of cutaneous propionibacteria.
|
J Appl Bacteriol
|
1982
|
0.90
|
|
18
|
Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
|
Br J Dermatol
|
2003
|
0.88
|
|
19
|
Benefit-risk assessment of acne therapies.
|
Lancet
|
1997
|
0.86
|
|
20
|
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
|
Health Technol Assess
|
2005
|
0.84
|
|
21
|
Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.
|
Br J Dermatol
|
1983
|
0.84
|
|
22
|
Propionibacterium acnes and acne.
|
Dermatology
|
1998
|
0.83
|
|
23
|
Toxic shock syndrome: the effect of solid phase materials on the physiology of Staphylococcus aureus.
|
Postgrad Med J
|
1985
|
0.83
|
|
24
|
Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.
|
Br J Dermatol
|
2005
|
0.82
|
|
25
|
Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions.
|
J Med Microbiol
|
1979
|
0.81
|
|
26
|
Should topical antibiotics be used for the treatment of acne vulgaris?
|
Br J Dermatol
|
1982
|
0.79
|
|
27
|
Does oral isotretinoin prevent Propionibacterium acnes resistance?
|
Dermatology
|
1997
|
0.78
|
|
28
|
Effects of tampon materials on the in-vitro physiology of a toxic shock syndrome strain of Staphylococcus aureus.
|
J Med Microbiol
|
1985
|
0.78
|
|
29
|
Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1 alpha production in vitro.
|
Dermatology
|
1998
|
0.78
|
|
30
|
Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc.
|
Br J Dermatol
|
1994
|
0.77
|
|
31
|
Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.
|
Br J Dermatol
|
2009
|
0.77
|
|
32
|
Minocycline for acne vulgaris: efficacy and safety.
|
Cochrane Database Syst Rev
|
2000
|
0.76
|
|
33
|
Inflammatory levels of interleukin 1 alpha are present in the majority of open comedones in acne vulgaris.
|
Arch Dermatol
|
1991
|
0.75
|
|
34
|
In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms.
|
Infect Immun
|
1995
|
0.75
|
|
35
|
The use of antibiotics in acne therapy: oral or topical administration?
|
J Antimicrob Chemother
|
1982
|
0.75
|
|
36
|
Production and partial purification of a peptide antibiotic from Staphylococcus epidermidis.
|
J Appl Bacteriol
|
1983
|
0.75
|
|
37
|
Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride.
|
Clin Exp Dermatol
|
1997
|
0.75
|
|
38
|
Cutaneous antimicrobial defense.
|
Clin Dermatol
|
1998
|
0.75
|
|
39
|
Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris.
|
Br J Dermatol
|
1994
|
0.75
|
|
40
|
Seborrhoea--an indicator for poor clinical response in acne patients treated with antibiotics.
|
Clin Exp Dermatol
|
1992
|
0.75
|
|
41
|
Interactions of tampon fibres with growth of Staphylococcus aureus in vitro.
|
Lancet
|
1983
|
0.75
|
|
42
|
Benzoyl peroxide and adapalene fixed combination: a novel agent for acne.
|
Br J Dermatol
|
2009
|
0.75
|
|
43
|
The effect of zinc and erythromycin on the growth of erythromycin-resistant and erythromycin-sensitive isolates of Propionibacterium acnes: an in-vitro study.
|
Br J Dermatol
|
1992
|
0.75
|
|
44
|
Topical antibiotics in acne therapy.
|
J Am Acad Dermatol
|
1981
|
0.75
|
|
45
|
The use of PCR to isolate a putative ABC transporter from Saccharopolyspora erythraea.
|
FEMS Microbiol Lett
|
1995
|
0.75
|
|
46
|
Topical antibiotics in acne therapy-continued.
|
J Am Acad Dermatol
|
1981
|
0.75
|